Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 12.00 (3.209%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MaxCyte signs strategic platform licence with Catamaran Bio

Wed, 04th Jan 2023 08:56

(Alliance News) - MaxCyte Inc on Wednesday said it signed a strategic platform licence with biotechnology company Catamaran Bio Inc.

MaxCyte, the US commercial cell-engineering company with an office in Cheshire, England, said the platform licence was to support Catamaran Bio's CAR-NK cell therapy programmes, allowing it to use MaxCyte's Flow Electroporation technology and ExPERT platform.

ExPERT delivers essential high-end performance for enabling the next wave of biological and cellular therapeutics, according to MaxCyte.

It will receive platform licensing fees and programme-related revenue in exchange.

"At MaxCyte, we are passionate about driving the discovery, development and manufacturing of next-generation, cell-based medicines to tackle complex diseases and cancer," said Doug Doerfler, chief executive officer at MaxCyte. "We are excited to support Catamaran with the advancement of their pipeline of differentiated CAR-NK cell therapies into and through the clinic."

Catamaran Bio's business model focuses on developing novel, off-the-shelf chimeric antigen receptor CAR-NK cell therapies to treat a broad range of cancers, particularly involving solid tumours.

The licence is alongside having developed its integrated suite of technologies platform Tailwind to engineer, expand and process NK cells into safe and effective cell therapy products for multiple cancer types.

Shares in MaxCyte were up 1.3% to 443.00 pence each in London on Wednesday morning.

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Dec 2021 15:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
23 Nov 2021 16:21

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

Read more
23 Nov 2021 15:25

Director dealings: Maxcyte chairman makes share purchase

(Sharecast News) - Maxcyte revealed on Tuesday that chairman Richard Douglas had acquired 20,000 ordinary shares in the AIM-listed cell-engineering company.

Read more
11 Nov 2021 21:26

TRADING UPDATES: iEnergizer and Volex post interim profit hikes

TRADING UPDATES: iEnergizer and Volex post interim profit hikes

Read more
11 Nov 2021 11:58

MaxCyte revenue jumps more than 50pc in third quarter

(Sharecast News) - Commercial cell engineering company MaxCyte reported total third quarter revenue of $10.1m in an update on Thursday, representing 50% growth compared to the same period in 2020.

Read more
3 Nov 2021 14:13

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers

Read more
29 Oct 2021 21:20

TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision

TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision

Read more
28 Oct 2021 19:19

TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus

TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus

Read more
22 Oct 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
1 Oct 2021 17:55

IN BRIEF: MaxCyte Chair Thompson to step down late October

IN BRIEF: MaxCyte Chair Thompson to step down late October

Read more
17 Sep 2021 17:50

IN BRIEF: MaxCyte to join Russell 2000 index in US on September 20

IN BRIEF: MaxCyte to join Russell 2000 index in US on September 20

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
6 Sep 2021 15:58

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
2 Aug 2021 21:22

IN BRIEF: MaxCyte underwriters exercise over-allotment option

IN BRIEF: MaxCyte underwriters exercise over-allotment option

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.